The DOI matches its Crossref record; 342 of the 342 references it cites were found in a registry or an index.
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Open accessAbstract
The release and absorption profile of an oral medication is influenced by the physicochemical properties of the drug and its formulation, as well as by the anatomy and physiology of the gastrointestinal (GI) tract. During drug development the bioavailability of a new drug is typically assessed in early clinical studies in a healthy adult population. However, many disease conditions are associated with an alteration of the anatomy and/or physiology of the GI tract. The same holds true for some subpopulations, such as paediatric or elderly patients, or populations with different ethnicity. The variation in GI tract conditions compared to healthy adults can directly affect the kinetics of drug absorption, and thus, safety and efficacy of an oral medication. This review provides an overview of GI tract properties in special populations compared to healthy adults and discusses how drug absorption is affected by these conditions. Particular focus is directed towards non-disease dependent conditions (age, sex, ethnicity, genetic factors, obesity, pregnancy), GI diseases (ulcerative colitis and Crohn's disease, celiac disease, cancer in the GI tract, Roux-en-Y gastric bypass, lactose intolerance, Helicobacter pylori infection, and infectious diseases of the GI tract), as well as systemic diseases that change the GI tract conditions (cystic fibrosis, diabetes, Parkinson's disease, HIV enteropathy, and critical illness). The current knowledge about GI conditions in special populations and their impact on drug absorption is still limited. Further research is required to improve confidence in pharmacokinetic predictions and dosing recommendations in the targeted patient population, and thus to ensure safe and effective drug therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Webb, A. K. (2006) · Cited by 4,369
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169 · cited 1×
“Furthermore, the altered microbiota induces inflammation that affects the GI mucosa (Zevin et al., 2016).”
BackgroundHolmes, G. K. T., & Cooke, W. T. (1984) · Cited by 2,638
Elborn, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00576-6 · Cited by 1,805
Sex bias in neuroscience and biomedical research
Beery, A. K., & Zucker, I. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.002 · Cited by 1,763
The Pancreas Cancer Microenvironment
Feig, C., Gopinathan, A., Neesse, A., Chan, D. S., Cook, N., & Tuveson, D. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3114 · Cited by 1,316
Measurement of gastrointestinal pH profiles in normal ambulant human subjects
Evans, D. F., Pye, G., Bramley, R., Clark, A. G., Dyson, T. J., & Hardcastle, J. D. (1988) · Gut · doi:10.1136/gut.29.8.1035 · Cited by 1,240
Sex Differences in Pharmacokinetics and Pharmacodynamics
Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00001 · Cited by 1,163
Mapping human microbiome drug metabolism by gut bacteria and their genes
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Nature · doi:10.1038/s41586-019-1291-3 · Cited by 1,160
Mehandru, S., Poles, M. A., Tenner-Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D., Racz, P., & Markowitz, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041196 · Cited by 1,146
Lebwohl, B., Sanders, D. S., & Green, P. H. R. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31796-8 · Cited by 1,065
Gastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., et al. (2018) · Science · doi:10.1126/science.aar3318 · Cited by 942
Simplified assessment of segmental colonic transit
Metcalf, A. M., Phillips, S. F., Zinsmeister, A. R., MacCarty, R. L., Beart, R. W., & Wolff, B. G. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90837-7 · Cited by 928
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 925
Microbiota and diabetes: an evolving relationship
Tilg, H., & Moschen, A. R. (2014) · Gut · doi:10.1136/gutjnl-2014-306928 · Cited by 853
(2001) · Drugs and the Pharmaceutical Sciences · doi:10.1201/9780824741969.axh · Cited by 818
Inflammatory Bowel Disease in Children and Adolescents
Rosen, M. J., Dhawan, A., & Saeed, S. A. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.1982 · Cited by 788
Effect of Obesity on the Pharmacokinetics of Drugs in Humans
Hanley, M. J., Abernethy, D. R., & Greenblatt, D. J. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318100-000000000-00000 · Cited by 773
Mustalahti, K., Catassi, C., Reunanen, A., Fabiani, E., Heier, M., McMillan, S., Murray, L., Metzger, M.-H., Gasparin, M., Bravi, E., et al. (2010) · Annals of Medicine · doi:10.3109/07853890.2010.505931 · Cited by 765
Metformin and the gastrointestinal tract
McCreight, L. J., Bailey, C. J., & Pearson, E. R. (2016) · Diabetologia · doi:10.1007/s00125-015-3844-9 · Cited by 733
Michielan, A., & D’Incà, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/628157 · Cited by 709 · cited 1×
“Inflammation can decrease the functional surface area of the intestines, but results from various studies indicate that it also can increase intestinal tight junction permeability (Michielan and D'Incà, 2015).”
BackgroundNUGENT, S. G., KUMAR, D., RAMPTON, D. S., & EVANS, D. F. (2001) · Gut · doi:10.1136/gut.48.4.571 · Cited by 700
Intestinal Microbiota Is Influenced by Gender and Body Mass Index
Haro, C., Rangel-Zúñiga, O. A., Alcalá-Díaz, J. F., Gómez-Delgado, F., Pérez-Martínez, P., Delgado-Lista, J., Quintana-Navarro, G. M., Landa, B. B., Navas-Cortés, J. A., Tena-Sempere, M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154090 · Cited by 671 · cited 1×
“A study demonstrated that women appear to have significantly higher levels of faecal bifidobacteria and Bilophila than men (Cross et al., 2018; Haro et al., 2016).”
BackgroundColorectal cancer development and advances in screening
Balchen, V., & Simon, K. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s109285 · Cited by 665
Predicting the Impact of Physiological and Biochemical Processes on Oral Drug Bioavailability
Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00179-x · Cited by 651
Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease
Hendrickson, B. A., Gokhale, R., & Cho, J. H. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.1.79-94.2002 · Cited by 630
Orditura, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1635 · Cited by 623
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L. X., & Amidon, G. L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600182 · Cited by 606
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
SCHILLER, C., FRÖHLICH, C. ‐., GIESSMANN, T., SIEGMUND, W., MÖNNIKES, H., HOSTEN, N., & WEITSCHIES, W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02683.x · Cited by 596
Patti, M., Houten, S. M., Bianco, A. C., Bernier, R., Larsen, P. R., Holst, J. J., Badman, M. K., Maratos‐Flier, E., Mun, E. C., Pihlajamaki, J., et al. (2009) · Obesity · doi:10.1038/oby.2009.102 · Cited by 591 · cited 1×
“dividuals who had undergone a RYGB 2–4 years before (n = 9), the serum concentration of bile acids was more than twofold higher than in overweight (n = 10) or severely obese individuals (n = 5) without bariatric surgery (Patti et al., 2009).”
BackgroundHIV infection and the gastrointestinal immune system
Brenchley, J. M., & Douek, D. C. (2008) · Mucosal Immunology · doi:10.1038/mi.2007.1 · Cited by 526
Physiologic and pharmacokinetic changes in pregnancy
Costantine, M. M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00065 · Cited by 523
Fleisher, D., Li, C., Zhou, Y., Pao, L., & Karim, A. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936030-00004 · Cited by 506
An Update on Inflammatory Bowel Disease
Sairenji, T., Collins, K. L., & Evans, D. V. (2017) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2017.07.010 · Cited by 499
The “Perfect Storm” for Type 1 Diabetes
Vaarala, O., Atkinson, M. A., & Neu, J. (2008) · Diabetes · doi:10.2337/db08-0331 · Cited by 497
Jones, H., Chen, Y., Gibson, C., Heimbach, T., Parrott, N., Peters, S., Snoeys, J., Upreti, V., Zheng, M., & Hall, S. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.37 · Cited by 488
Self-citationMudie, D. M., Murray, K., Hoad, C. L., Pritchard, S. E., Garnett, M. C., Amidon, G. L., Gowland, P. A., Spiller, R. C., Amidon, G. E., & Marciani, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500210c · Cited by 486
Koziolek, M., Grimm, M., Becker, D., Iordanov, V., Zou, H., Shimizu, J., Wanke, C., Garbacz, G., & Weitschies, W. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24274 · Cited by 464
Population-Based Mechanistic Prediction of Oral Drug Absorption
Jamei, M., Turner, D., Yang, J., Neuhoff, S., Polak, S., Rostami-Hodjegan, A., & Tucker, G. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9099-y · Cited by 452
REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION
Aitken, A. E., Richardson, T. A., & Morgan, E. T. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141059 · Cited by 448
Do Women Have More Adverse Drug Reactions?
Rademaker, M. (2001) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200102060-00001 · Cited by 432
Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches
Amidon, S., Brown, J. E., & Dave, V. S. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0350-9 · Cited by 423
The microbiome as a human organ
Baquero, F., & Nombela, C. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03916.x · Cited by 415
Morínigo, R., Moizé, V., Musri, M., Lacy, A. M., Navarro, S., Marín, J. L., Delgado, S., Casamitjana, R., & Vidal, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0904 · Cited by 397
Mechanisms of drug resistance in colon cancer and its therapeutic strategies
Hu, T., Li, Z., Gao, C.-Y., & Cho, C. H. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6876 · Cited by 381
Abduljalil, K., Furness, P., Johnson, T. N., Rostami-Hodjegan, A., & Soltani, H. (2012) · Clinical Pharmacokinetics · doi:10.2165/11597440-000000000-00000 · Cited by 371
Upper Gastrointestinal pH in Seventy-Nine Healthy, Elderly, North American Men and Women
Russell, T. L., Berardi, R. R., Barnett, J. L., Dermentzoglou, L. C., Jarvenpaa, K. M., Schmaltz, S. P., & Dressman, J. B. (1993) · Pharmaceutical Research · doi:10.1023/a:1018970323716 · Cited by 367
Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States
Coghill, A. E., Shiels, M. S., Suneja, G., & Engels, E. A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5967 · Cited by 365
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs
Cascorbi, I. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.009 · Cited by 355
Rao, S. S. C., Kuo, B., McCallum, R. W., Chey, W. D., DiBaise, J. K., Hasler, W. L., Koch, K. L., Lackner, J. M., Miller, C., Saad, R., et al. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.01.017 · Cited by 345
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review
Pariente, G., Leibson, T., Carls, A., Adams-Webber, T., Ito, S., & Koren, G. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002160 · Cited by 336
Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Diabetes Care · doi:10.2337/dc12-1609 · Cited by 335
Intestinal drug transporters: An overview
Estudante, M., Morais, J. G., Soveral, G., & Benet, L. Z. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.042 · Cited by 330
Thyroxine in Goiter, Helicobacter pylori Infection, and Chronic Gastritis
Centanni, M., Gargano, L., Canettieri, G., Viceconti, N., Franchi, A., Fave, G. D., & Annibale, B. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043903 · Cited by 329 · cited 1×
“tients, as observed with thyroxine (Centanni et al., 2006), L-dopa (Pierantozzi et al.”
BackgroundExocrine Pancreas Function in Premature and Full Term Neonates
Zoppi, G., Andreotti, G., Pajno-Ferrara, F., Dm, N., & Gaburro, D. (1972) · Pediatric Research · doi:10.1203/00006450-197212000-00005 · Cited by 323
Di Cagno, R., De Angelis, M., De Pasquale, I., Ndagijimana, M., Vernocchi, P., Ricciuti, P., Gagliardi, F., Laghi, L., Crecchio, C., Guerzoni, M. E., et al. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-219 · Cited by 317 · cited 5×
“The total bile acid concentration was comparable between normal weight (mean BMI = 23.2 kg/m2) and obese populations (mean BMI = 47.2 kg/m2) in the fasted state (Diakidou et al., 2009).”
BackgroundInfluentialGender differences in the effects of cardiovascular drugs
Tamargo, J., Rosano, G., Walther, T., Duarte, J., Niessner, A., Kaski, J., Ceconi, C., Drexel, H., Kjeldsen, K., Savarese, G., et al. (2017) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvw042 · Cited by 317
PBPK models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Aarons, L., Bergstrand, M., Bolger, M. B., Galetin, A., Hatley, O., Jamei, M., Lloyd, R., Pepin, X., Rostami-Hodjegan, A., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.008 · Cited by 315
Wolking, S., Schaeffeler, E., Lerche, H., Schwab, M., & Nies, A. T. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0267-1 · Cited by 309
Influence of age on thirst and fluid intake
KENNEY, W. L., & CHIU, P. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200109000-00016 · Cited by 304
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.003 · Cited by 298
The influence of gut microbiota on drug metabolism and toxicity
Li, H., He, J., & Jia, W. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1121234 · Cited by 278
Cichero, J. A. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-54 · Cited by 273
Sex bias exists in basic science and translational surgical research
Yoon, D. Y., Mansukhani, N. A., Stubbs, V. C., Helenowski, I. B., Woodruff, T. K., & Kibbe, M. R. (2014) · Surgery · doi:10.1016/j.surg.2014.07.001 · Cited by 270
Gastrointestinal Complications of Obesity
Camilleri, M., Malhi, H., & Acosta, A. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.052 · Cited by 269
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
Zevin, A. S., McKinnon, L., Burgener, A., & Klatt, N. R. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000234 · Cited by 267
A systematic review of drug absorption following bariatric surgery and its theoretical implications
Padwal, R., Brocks, D., & Sharma, A. M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00614.x · Cited by 263
Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
Linnebjerg, H., Park, S., Kothare, P. A., Trautmann, M. E., Mace, K., Fineman, M., Wilding, I., Nauck, M., & Horowitz, M. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.07.003 · Cited by 261
Hebert, M., Easterling, T., Kirby, B., Carr, D., Buchanan, M., Rutherford, T., Thummel, K., Fishbein, D., & Unadkat, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.1 · Cited by 259
Drozdzik, M., Gröer, C., Penski, J., Lapczuk, J., Ostrowski, M., Lai, Y., Prasad, B., Unadkat, J. D., Siegmund, W., & Oswald, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500330y · Cited by 258
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K., Brewster, M., Dressman, J., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 257
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
Pinheiro, C., Longatto-Filho, A., Scapulatempo, C., Ferreira, L., Martins, S., Pellerin, L., Rodrigues, M., Alves, V. A. F., Schmitt, F., & Baltazar, F. (2008) · Virchows Archiv · doi:10.1007/s00428-007-0558-5 · Cited by 255
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Grasso, C., Jansen, G., & Giovannetti, E. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.026 · Cited by 253
Hebert, M., Ma, X., Naraharisetti, S., Krudys, K., Umans, J., Hankins, G., Caritis, S., Miodovnik, M., Mattison, D., Unadkat, J., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.5 · Cited by 252
Medication and nutrient administration considerations after bariatric surgery
Miller, A. D., & Smith, K. M. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060033 · Cited by 249
Pathologic Features and Clinical Significance of ???Backwash??? Ileitis in Ulcerative Colitis
Haskell, H., Andrews, C. W., Reddy, S. I., Dendrinos, K., Farraye, F. A., Stucchi, A. F., Becker, J. M., & Odze, R. D. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000176435.19197.88 · Cited by 248
Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions
Riethorst, D., Mols, R., Duchateau, G., Tack, J., Brouwers, J., & Augustijns, P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24603 · Cited by 245
Self-citationEffects of estrogen on the basal ganglia
Van Hartesveldt, C., & Joyce, J. N. (1986) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(86)90029-1 · Cited by 238
Effect of grapefruit juice on digoxin pharmacokinetics in humans.
Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., & Funck‐Brentano, C. (2001) · PubMed · Cited by 234
The role of ABC transporters in progression and clinical outcome of colorectal cancer
Hlavata, I., Mohelnikova-Duchonova, B., Vaclavikova, R., Liska, V., Pitule, P., Novak, P., Bruha, J., Vycital, O., Holubec, L., Treska, V., et al. (2012) · Mutagenesis · doi:10.1093/mutage/ger075 · Cited by 227
Sjöberg, Å., Lutz, M., Tannergren, C., Wingolf, C., Borde, A., & Ungell, A.-L. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.007 · Cited by 226
Self-citationA Review of Food–Drug Interactions on Oral Drug Absorption
Deng, J., Zhu, X., Chen, Z., Fan, C. H., Kwan, H. S., Wong, C. H., Shek, K. Y., Zuo, Z., & Lam, T. N. (2017) · Drugs · doi:10.1007/s40265-017-0832-z · Cited by 226
Smit, C., De Hoogd, S., Brüggemann, R. J. M., & Knibbe, C. A. J. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1440287 · Cited by 225
Gastrointestinal dysfunction in Parkinson's Disease
Jost, W. H. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.020 · Cited by 222
Oral Drug Absorption: Prediction and Assessment
Dressman, J., & Lennernäs, H. (2000) · Medical Entomology and Zoology · Cited by 217
Van Thiel, D. H., Gavaler, J. S., Joshi, S. N., Sara, R. K., & Stremple, J. (1977) · Gastroenterology · doi:10.1016/s0016-5085(77)80151-0 · Cited by 215
Smith, C. D., Herkes, S. B., Behrns, K. E., Fairbanks, V. F., Kelly, K. A., & Sarr, M. G. (1993) · Annals of Surgery · doi:10.1097/00000658-199307000-00014 · Cited by 213
Odstrcil, E. A., Martinez, J. G., Santa Ana, C. A., Xue, B., Schneider, R. E., Steffer, K. J., Porter, J. L., Asplin, J., Kuhn, J. A., & Fordtran, J. S. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29870 · Cited by 209
Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation
Heikkinen, T. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(02)17634-x · Cited by 209
Berggren, S., Gall, C., Wollnitz, N., Ekelund, M., Karlbom, U., Hoogstraate, J., Schrenk, D., & Lennernäs, H. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0600687 · Cited by 208
Banerjee, A., Pathak, S., Subramanium, V. D., G., D., Murugesan, R., & Verma, R. S. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.006 · Cited by 204
The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.
Enright, E. F., Gahan, C. G. M., Joyce, S. A., & Griffin, B. T. (2016) · PubMed · Cited by 202
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., Fedele, E., Sancesario, G., Bernardi, G., Bergamaschi, A., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000221672.01272.ba · Cited by 199
ACQUIRED IMMUNODEFICIENCY SYNDROME WITH SEVERE GASTROINTESTINAL MANIFESTATIONS IN HAITI
Malebranche, R., Guérin, J. M., Laroche, A. C., Elie, R., Spira, T., Drotman, P., Arnoux, E., Pierre, G. D., Pean-Guichard, C., Morisset, P. H., et al. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90868-1 · Cited by 199
Grapefruit Juice Activates P-Glycoprotein-Mediated Drug Transport
Soldner, A., Christians, U., Susanto, M., Wacher, V. J., Silverman, J. A., & Benet, L. Z. (1999) · Pharmaceutical Research · doi:10.1023/a:1011902625609 · Cited by 193
Does sex matter? The influence of gender on gastrointestinal physiology and drug delivery
Freire, A. C., Basit, A. W., Choudhary, R., Piong, C. W., & Merchant, H. A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.069 · Cited by 190
Self-citationKang, H. C., Kim, I.-J., Park, J.-H., Shin, Y., Ku, J.-L., Jung, M. S., Yoo, B. C., Kim, H. K., & Park, J.-G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1025-3 · Cited by 190
The role of the intestinal microbiota in enteric infection
Sekirov, I., & Finlay, B. B. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.172742 · Cited by 189
Deligiannidis, K. M., Byatt, N., & Freeman, M. P. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000087 · Cited by 186
Dirksen, C., Damgaard, M., Bojsen‐Møller, K. N., Jørgensen, N. B., Kielgast, U., Jacobsen, S. H., Naver, L. S., Worm, D., Holst, J. J., Madsbad, S., et al. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12087 · Cited by 184
Brouwer, K., Aleksunes, L., Brandys, B., Giacoia, G., Knipp, G., Lukacova, V, Meibohm, B., Nigam, S., Rieder, M., de Wildt, S., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.176 · Cited by 184
Self-citationGastric emptying and orocecal transit time in pregnancy
Chiloiro, M., Darconza, G., Piccioli, E., De Carne, M., Clemente, C., & Riezzo, G. (2001) · Journal of Gastroenterology · doi:10.1007/s005350170056 · Cited by 183
Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum
Moreno, M. P. D. L. C., Oth, M., Deferme, S., Lammert, F., Tack, J., Dressman, J., & Augustijns, P. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.8.0009 · Cited by 180
Self-citationDiabetic gastroparesis: what we have learned and had to unlearn in the past 5 years: Figure 1
Kashyap, P., & Farrugia, G. (2010) · Gut · doi:10.1136/gut.2009.199703 · Cited by 175
Glyphosate, pathways to modern diseases II: Celiac sprue and gluten intolerance
Samsel, A., & Seneff, S. (2013) · Interdisciplinary Toxicology · doi:10.2478/intox-2013-0026 · Cited by 175
Understanding the role of the gut ecosystem in diabetes mellitus
Aw, W., & Fukuda, S. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12673 · Cited by 172
Gutmann, H., Hruz, P., Zimmermann, C., Beglinger, C., & Drewe, J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.031 · Cited by 171
Neff, K., Olbers, T., & le Roux, C. W. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-8 · Cited by 171
Kumar, R., Lieske, J. C., Collazo-Clavell, M. L., Sarr, M. G., Olson, E. R., Vrtiska, T. J., Bergstralh, E. J., & Li, X. (2011) · Surgery · doi:10.1016/j.surg.2010.11.015 · Cited by 170
Effect of pregnancy on the pharmacokinetics of caffeine
Knutti, R., Rothweiler, H., & Schlatter, C. (1981) · European Journal of Clinical Pharmacology · doi:10.1007/bf00637512 · Cited by 168
Rubio‐Tapia, A., & Murray, J. A. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283365263 · Cited by 168
Insight to drug delivery aspects for colorectal cancer
Gulbake, A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.582 · Cited by 167
Poles, M. A., Elliott, J., Taing, P., Anton, P. A., & Chen, I. S. Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8390-8399.2001 · Cited by 166
An evaluation of gastric emptying times in pregnancy and the puerperium
Whitehead, E. M., Smith, M., Dean, Y., & O'Sullivan, G. (1993) · Anaesthesia · doi:10.1111/j.1365-2044.1993.tb06793.x · Cited by 164
Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis
Heyman, M., Abed, J., Lebreton, C., & Cerf-Bensussan, N. (2012) · Gut · doi:10.1136/gutjnl-2011-300327 · Cited by 163
Sharpstone, D. R., Neild, P. J., Crane, R., Taylor, C., Hodgson, C. L., Sherwood, R. A., Gazzard, B., & Bjarnason, I. (1999) · Gut · doi:10.1136/gut.45.1.70 · Cited by 160
Bonner, J. J., Vajjah, P., Abduljalil, K., Jamei, M., Rostami‐Hodjegan, A., Tucker, G. T., & Johnson, T. N. (2015) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1937 · Cited by 159
Johnson, T. N., Tanner, M. S., Taylor, C. J., & Tucker, G. T. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01370.x · Cited by 156
LOCALIZATION AND mRNA EXPRESSION OF CYP3A AND P-GLYCOPROTEIN IN HUMAN DUODENUM AS A FUNCTION OF AGE
Fakhoury, M., Litalien, C., Médard, Y., Cavé, H., Ezzahir, N., Peuchmaur, M. M., & Jacqz-Aigrain, É. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005611 · Cited by 155
Unraveling the Ties between Celiac Disease and Intestinal Microbiota
Sanz, Y., Palma, G. D., & Laparra, J. M. (2011) · International Reviews of Immunology · doi:10.3109/08830185.2011.599084 · Cited by 154
Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine
Hartmanshenn, C., Scherholz, M. L., & Androulakis, I. P. (2016) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-016-9492-y · Cited by 154
Tannergren, C., Bergendal, A., Lennernäs, H., & Abrahamsson, B. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800261a · Cited by 153
Ethnic or Racial Differences Revisited
Chen, M. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00001 · Cited by 153
Paediatric oral biopharmaceutics: Key considerations and current challenges
Batchelor, H. K., Fotaki, N., & Klein, S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.006 · Cited by 152
Self-citationMechanisms underlying food–drug interactions: Inhibition of intestinal metabolism and transport
Won, C. S., Oberlies, N. H., & Paine, M. F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.001 · Cited by 150
Sarosiek, I., Selover, K., KATZ, L. A., Semler, J. R., Wilding, G. E., Lackner, J. M., Sitrin, M. D., Kuo, B., Chey, W. D., Hasler, W. L., et al. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04162.x · Cited by 147
Behrns, K. E., Smith, C. D., & Sarr, M. G. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02090203 · Cited by 146
Mechanisms of disease: inborn errors of bile acid synthesis
Sundaram, S. S., Bove, K. E., Lovell, M. A., & Sokol, R. J. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1179 · Cited by 146
Simonen, M., Dali-Youcef, N., Kaminska, D., Venesmaa, S., Käkelä, P., Pääkkönen, M., Hallikainen, M., Kolehmainen, M., Uusitupa, M., Moilanen, L., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0673-5 · Cited by 145
Diakidou, A., Vertzoni, M., Goumas, K., Söderlind, E., Abrahamsson, B., Dressman, J., & Reppas, C. I. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9927-x · Cited by 144
Anthropometric correlates of intragastric pressure
El‐Serag, H. B., Tran, T., Richardson, P., & Ergun, G. A. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500535402 · Cited by 144
Droździk, M., Busch, D., Łapczuk-Romańska, J., Müller, J., Ostrowski, M., Kurzawski, M., & Oswald, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.967 · Cited by 144
Let thy food be thy medicine….when possible
Witkamp, R. F., & van Norren, K. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.026 · Cited by 144
Ford, R. P. K., Menzies, I. S., Phillips, A. D., Walker‐Smith, J., & TURNER, M. W. (1985) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-198508000-00012 · Cited by 143
Influence of Race or Ethnicity on Pharmacokinetics of Drugs
Johnson, J. A. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9702168 · Cited by 142
National Institutes of Health Consensus Development Conference: Lactose Intolerance and Health
Suchy, F. J., Brannon, P. M., Carpenter, T. O., Fernandez, J. R., Gilsanz, V., Gould, J. B., Hall, K., Hui, S. L., Lupton, J., Mennella, J., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-12-201006150-00248 · Cited by 142
Screening for celiac disease in the general population and in high‐risk groups
Ludvigsson, J. F., Card, T. R., Kaukinen, K., Bai, J. C., Zingone, F., Sanders, D. S., & Murray, J. A. (2014) · United European Gastroenterology Journal · doi:10.1177/2050640614561668 · Cited by 141
Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil
McGready, R. M., Stepniewska, K., Seaton, E. D., Cho, T., Cho, D., Ginsberg, A., Edstein, M. D., Ashley, E. A., Looareesuwan, S., White, N. J., et al. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0651-x · Cited by 140
Webber, L., Divajeva, D., Marsh, T., McPherson, K., Brown, M., Galea, G., & Breda, J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004787 · Cited by 139
Gastric capacity in normal, obese, and bulimic women
Geliebter, A., & Hashim, S. A. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00619-9 · Cited by 138
Brain-gut axis in the pathogenesis of Helicobacter pylori infection
Budzyński, J., & Kłopocka, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5212 · Cited by 138
Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia?
Mearin, F., Ribot, X. D., Mearin, F., Salas, A., Varas, M. J., Cucala, M., Bartolomé, R. M., Armengol, J., & Malagelada, J. (1995) · Gut · doi:10.1136/gut.37.1.47 · Cited by 136
Grimm, M. F., Koziolek, M., Kühn, J., & Weitschies, W. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.03.002 · Cited by 134
Evers, R., Piquette‐Miller, M., Polli, J. W., Rüssel, F. G. M., Sprowl, J. A., Tohyama, K., Ware, J. A., de Wildt, S. N., Xie, W., & Brouwer, K. L. R. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1115 · Cited by 132
Gastrointestinal Complications of Cystic Fibrosis
Gelfond, D., & Borowitz, D. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.006 · Cited by 131
Mouly, S. J., Lloret‐Linares, C., Sellier, P., Sène, D., & Bergmann, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.038 · Cited by 131
Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments
Poirier, A.-A., Aubé, B., Côté, M., Morin, N., Di Paolo, T., & Soulet, D. (2016) · Parkinson s Disease · doi:10.1155/2016/6762528 · Cited by 130
The Effect of Bariatric Surgery on Intestinal Absorption and Transit Time
Carswell, K. A., Vincent, R. P., Belgaumkar, A. P., Sherwood, R. A., Amiel, S. A., Patel, A. G., & le Roux, C. W. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1166-x · Cited by 130
Koziolek, M., Grimm, M. F., Garbacz, G., Kühn, J., & Weitschies, W. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500022u · Cited by 130
T84 monolayers are superior to Caco-2 as a model system of colonocytes
Devriese, S., den Bossche, L. V., Welden, S. V., Holvoet, T., Pinheiro, I., Hindryckx, P., Vos, M. D., & Laukens, D. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1539-7 · Cited by 129
Correlations between intra-abdominal pressure and obesity-related co-morbidities
Varela, J. E., Hinojosa, M. W., & Nguyen, N. T. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.04.003 · Cited by 125
Joshi, G., Kumar, A., & Sawant, K. K. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.04.014 · Cited by 125
The effects of pharmaceutical excipients on drug disposition
Buggins, T. R., Dickinson, P. A., & Taylor, G. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.017 · Cited by 125
Abdulkarim, A. S., & Murray, J. A. (2002) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-002-0004-3 · Cited by 125
Mechanism of direct bicarbonate transport by the CFTR anion channel
Tang, L., Fatehi, M., & Linsdell, P. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.10.004 · Cited by 124
Recognition, assessment, and management of coeliac disease: summary of updated NICE guidance
Downey, L. E., Houten, R., MURCH, S. H., & Longson, D. (2015) · BMJ · doi:10.1136/bmj.h4513 · Cited by 122
Drug resistance related to aberrant glycosylation in colorectal cancer
Very, N., Lefebvre, T., & Yazidi‐Belkoura, I. E. (2017) · Oncotarget · doi:10.18632/oncotarget.22377 · Cited by 122
Wisén, O., & Johansson, C. (1992) · Metabolism · doi:10.1016/0026-0495(92)90073-j · Cited by 119
Jackson, S. J., Leahy, F. E., McGowan, A. A., Bluck, L. J. C., Coward, W. A., & Jebb, S. A. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.0344.x · Cited by 117
Understanding and applying pharmacometric modelling and simulation in clinical practice and research
Standing, J. F. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13119 · Cited by 117
Gastrointestinal Transit Disorders in Patients with Insulin-Treated Diabetes mellitus
Wegener, M., Börsch, G., Schaffstein, J., Luerweg, C., & Leverkus, F. (2008) · Digestive Diseases · doi:10.1159/000171237 · Cited by 116
Gender‐Specific Effects on Verapamil Pharmacokinetics and Pharmacodynamics in Humans
KRECICSHEPARD, M., Barnas, C., SLIMKO, J., Jones, M. P., & Schwartz, J. B. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008883 · Cited by 116
Peters, S. A., Jones, C. R., Ungell, A.-L. B., & Hatley, O. J. D. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0351-6 · Cited by 115
Self-citationInflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children
Vet, N. J., Brussee, J. M., de Hoog, M., Mooij, M. G., Verlaat, C. W. M., Jerchel, I. S., van Schaik, R. H. N., Koch, B. C. P., Tibboel, D., Knibbe, C. A. J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2114oc · Cited by 111
Self-citationDrug absorption, distribution, metabolism and excretion considerations in critically ill adults
Roberts, D. J., & Hall, R. I. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.799137 · Cited by 110
Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin
Padwal, R. S., Gabr, R. Q., Sharma, A. M., Langkaas, L.-A., Birch, D. W., Karmali, S., & Brocks, D. R. (2011) · Diabetes Care · doi:10.2337/dc10-2140 · Cited by 109
Gastric emptying of solids in morbid obesity.
Tosetti, C., Corinaldesi, R., Stanghellini, V., Pasquali, R., Corbelli, C., Zoccoli, G., Febo, G. D., Monetti, N., & Barbara, L. (1996) · PubMed · Cited by 109
Gröer, C., Busch, D., Patrzyk, M., Beyer, K., Busemann, A., Heidecke, C.-D., Droździk, M., Siegmund, W., & Oswald, S. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.08.016 · Cited by 108
Adamska, A., & Falasca, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i29.3222 · Cited by 108
Preference for pharmaceutical formulation and treatment process attributes
Stewart, K. D., Johnston, J. A., Matza, L. S., Curtis, S., Havel, H. A., Sweetana, S. A., & Gelhorn, H. L. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s101821 · Cited by 106
Thompson, C. M., Johns, D. O., Sonawane, B. R., Barton, H. A., Hattis, D. B., Tardif, R., & Krishnan, K. (2008) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937400802545060 · Cited by 105
Broe, A., Pottegård, A., Lamont, R., Jørgensen, J. S., & Damkier, P. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12806 · Cited by 104
Effinger, A., O’Driscoll, C. M., McAllister, M. S., & Fotaki, N. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12928 · Cited by 101
Bennink, R. J., Peeters, M., den Maegdenbergh, V. V., Geypens, B. J., Rutgeerts, P., Roo, M. D., & Mortelmans, L. A. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050298 · Cited by 99
Measurement of gastric emptying after gastric bypass surgery using radionuclides
Horowitz, M., Cook, D. J., Collins, P., Harding, P. E., Hooper, M. J., Walsh, J. F., & Shearman, D. J. C. (1982) · British journal of surgery · doi:10.1002/bjs.1800691108 · Cited by 99
Heyes, N., Kapoor, P., & Kerr, I. D. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.083030 · Cited by 99
Neal-Kluever, A., Fisher, J. W., GRYLACK, L. J., Kakiuchi-Kiyota, S., & Halpern, W. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.084418 · Cited by 98
CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
Chen, L. L., & Prasad, G. V. R. (2018) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s107710 · Cited by 96
Ghobadi, C., Johnson, T. N., Aarabi, M., Almond, L. M., Allabi, A. C., Rowland‐Yeo, K., Jamei, M., & Rostami‐Hodjegan, A. (2011) · Clinical Pharmacokinetics · doi:10.2165/11594420-000000000-00000 · Cited by 94
Gastrointestinal Dysfunction in Parkinson’s Disease
Skjærbæk, C., Knudsen, K., Horsager, J., & Borghammer, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030493 · Cited by 94
Postprandial plasma bile acid responses in normal weight and obese subjects
Glicksman, C., Pournaras, D. J., Wright, M., Roberts, R., Mahon, D., Welbourn, R., Sherwood, R., Alaghband-Zadeh, J., & le Roux, C. W. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010040 · Cited by 94
Fasting gastric pH and its relationship to true hypochlorhydria in humans
Feldman, M. L., & Barnett, C. C. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01297133 · Cited by 92
Edwards, M. R., Dai, R., & Ahmed, S. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00478 · Cited by 92
Influence of aging on gastrointestinal transit time. An ultrasonographic and radiologic study.
Brogna, A., Ferrara, R., Bucceri, A., Lanteri, E., & Catalano, F. (1999) · Investigative Radiology · doi:10.1097/00004424-199905000-00005 · Cited by 90
Gastric juice acidity in upper gastrointestinal diseases
Lu, P. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i43.5496 · Cited by 88
Ontogeny of oral drug absorption processes in children
Mooij, M. G., de Koning, B. A., Huijsman, M. L., & de Wildt, S. N. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.698261 · Cited by 88
Self-citationAshiru-Oredope, D. A. I., Patel, R., & Basit, A. W. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9635-y · Cited by 88
Self-citationEffect of Diet on the Development of Drug Metabolism by Cytochrome P-450 Enzymes in Healthy Infants
Blake, M. J., Abdel‐Rahman, S. M., Pearce, R. E., Leeder, J. S., & Kearns, G. L. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000245909.74166.00 · Cited by 87
Hsueh, C., Hsu, V., Zhao, P., Zhang, L., Giacomini, K. M., & Sm, H. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.750 · Cited by 87
Sexual dimorphism of cardiometabolic dysfunction: Gut microbiome in the play?
Cross, T.-W. L., Kasahara, K., & Rey, F. E. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.016 · Cited by 87
Pierantozzi, M., Pietroiusti, A., Sancesario, G., Lunardi, G., Fedele, E., Giacomini, P., Frasca, S., Galante, A., Marciani, M. G., & Stanzione, P. (2001) · Neurological Sciences · doi:10.1007/s100720170061 · Cited by 85
Effect of obesity on gastroesophageal resistance to flow in man
Zacchi, P., Mearin, F., Humbert, P., et al. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01296818 · Cited by 85
Clinical Pharmacology Studies in Critically Ill Children
Thakkar, N., Salerno, S. N., Hornik, C. P. V., & González, D. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2033-y · Cited by 85
Measurement of gastric emptying in the critically ill
Kar, P., Jones, K. L., Horowitz, M., Chapman, M. J., & Deane, A. M. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.11.003 · Cited by 84
Singh‐Manoux, A., Guéguen, A., Ferrie, J. E., Shipley, M. J., Martikainen, P., Bonenfant, S., Goldberg, M., & Marmot, M. G. (2008) · American Journal of Public Health · doi:10.2105/ajph.2006.107912 · Cited by 84
Cited by
Cao, F., Jin, L., Gao, Y., Ding, Y., Wen, H., Qian, Z., Zhang, C., Hong, L., Yang, H., Zhang, J., et al. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01346-x · Cited by 472
The Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Self-citationOral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lu, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 353
Let’s talk about sex: Differences in drug therapy in males and females
Madla, C. M., Gavins, F. K. H., Merchant, H. A., Orlu, M., Murdan, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.014 · Cited by 167
Self-citation
Metadata
- Authors
- Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., Madla, C. M., Matthys, C., Miljuš, G., Mooij, M. G., Parrott, N., Ungell, A.-L., de Wildt, S. N., Orlu, M., Klein, S., & Müllertz, A.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 147
- Pages
- 105280
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W3008414764
- Cited by
- 320
- References
- 342
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.